Loading company…
Rezo Therapeutics develops computational tools to support drug discovery.
Rezo Therapeutics develops a platform combining proteomics, genetics, structural biology and chemical biology to map molecular disease networks and identify drug targets. The California-based company was co-founded by Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, George Scangos and Norbert Bischofbergerin, and initially focuses on oncology. In November 2022, it raised USD 78 million in Series A funding co-led by a16z, Norwest Venture Partners and SR One.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in